The pharmaceutical industry has called for abolishing “off-year” drug price revisions in the run-up to the formulation of the 2024 Basic Policy on Economic and Fiscal Management and Reform (honebuto) later in June. It appears that its lobbying efforts have…
HOME > LATEST
LATEST
-
REGULATORY Health Minister Acknowledges Changes after 2016 Decision on Off-Year Revisions
May 28, 2024
-
BUSINESS Alzheimer’s Med Leqembi Approved in South Korea, Its 4th Market
May 28, 2024
-
REGULATORY MHLW Panel OKs Avigan for SFTS with Strings Attached, Shionogi COVID Jab Only for Primary Use
May 27, 2024
-
BUSINESS Sawai Recalls Antibiotic Cefdinir Manufactured by Choseido, 4 Other APIs
May 27, 2024
-
BUSINESS MSD Chief Urges Further Reform around Spillovers; Japan Sales Up 11% in 2023
May 27, 2024
-
BUSINESS Choseido Violates GMP Once Again with Cefdinir, More Cases Being Probed
May 27, 2024
-
REGULATORY LDP’s Social Security Commission Urges Govt to Revisit Off-Year Drug Price Revisions
May 24, 2024
-
ORGANIZATION JPMA, PhRMA, EFPIA to Jointly Survey Views on 2024 Drug Pricing Reform
May 24, 2024
-
REGULATORY MHLW Proposes Inclusion of Prevenar 20 in National Immunization for Children
May 24, 2024
-
BUSINESS AnGes to Roll Out Progeria Treatment Zokinvy on May 27
May 24, 2024
-
BUSINESS Big 4 Wholesalers Log 11.7% Growth in Operating Profit, 3 Hit 1%-Plus Margins
May 24, 2024
-
REGULATORY MHLW Panel Draws Up Plans for Generic Industry Shakeup in Final Report
May 23, 2024
-
REGULATORY Japan Govt to Launch Public-Private Forum to Attract Investments
May 23, 2024
-
REGULATORY No Inclusion of Males in National HPV Vaccinations for Now: MHLW Panel
May 23, 2024
-
BUSINESS AstraZeneca’s Beyfortus, Pfizer’s Elrexfio and More Now Available in Japan
May 23, 2024
-
BUSINESS Santen Recalls All Lots of Diquas LX, Halts Supply for Preservative Issue
May 23, 2024
-
REGULATORY Japan to Survey Uneven Distribution of Yakkasa, Look into Voluntary Chain Deals Too
May 23, 2024
-
BUSINESS Daiichi Sankyo Sets Up New Research Sites in US, Germany
May 23, 2024
-
BUSINESS Otsuka Axes Alzheimer’s Agitation Drug, Cuts Half-Year Profit Outlook
May 23, 2024
-
BUSINESS Bridion Generics Now Available; Maruishi to Launch on May 27
May 23, 2024
ページ
The pharmaceutical industry is ever-changing. Recruiters must evolve accordingly and prepare well in advance for future talent needs.This means predicting the changes and trends that will impact the market, industry, and your organization, and how this will affect talent requirements.…
The Japanese health ministry on December 22 approved a batch of medicines for additional indications, including Otsuka Pharmaceutical’s atypical antipsychotic Rexulti (brexpiprazole) and Zenyaku Kogyo’s anti-CD20 antibody Rituxan (rituximab).Rexulti is now newly indicated for the treatment of depression and depressive…
Authorized generic (AG) strategies taken by innovative drug makers might help soften the impact of generic competition in their businesses but such tactics might also accelerate the application of “G1”/“G2” price cuts for their off-patent brand-name medicines, a Jiho tally…
Japan’s health ministry announced new NHI prices to be applied in April under the FY2022 drug price revision in the official gazette on March 4, with the earlier application of so-called “G1” price cuts to be implemented for the first…